ESC 365 - Thrombus perspectives: a comparative analysis of DOACs and warfarin

ESC2025 Premium Access

Thrombus perspectives: a comparative analysis of DOACs and warfarin

Session: New perspectives in cardiology (2) - Antithrombotic pharmacotherapy

Topic: Anticoagulants

Speaker: Doctor B. Resende (Coimbra, PT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Bernardo Lisboa Resende

Coimbra Hospital and University Center, Coimbra (Portugal)

0 follower

10 more presentations in this session

Discussant - Antithrombotic pharmacotherapy

Safety and efficacy of factor XI/XIa inhibitors compared to factor Xa inhibitors for stroke prophylaxis in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials

Speaker: Mr G. Arrighini (Bologna, IT)

Sex differences in dual antiplatelet therapy de-Escalation strategies in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis

Speaker: Doctor G. Occhipinti (Barcelona, ES)

Direct oral anticoagulants versus warfarin or vitamin k antagonists in patients with left-sided bioprosthetic valves and atrial fibrillation: a meta-analysis

Speaker: Doctor A. Abdelaziz (Damietta, EG)

Platelet reactivity of clopidogrel and aspirin with or without omeprazole in diabetes mellitus and coronary artery disease in thailand: a randomised double-blind placebo-controlled cross-over trial

Speaker: Doctor M. Thungthienthong (Bangkok, TH)

Access the full session

New perspectives in cardiology (2) - Antithrombotic pharmacotherapy

Speakers: Doctor B. Resende, Mr G. Arrighini, Doctor G. Occhipinti, Doctor A. Abdelaziz, Doctor M. Thungthienthong

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources